Position in WAT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$548,308
+$107,862 QoQ
Shares Held
1,462
-1.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#601
of 1,173 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in WAT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SevenBridge Financial Group, LLC holds $3,834,722 across 2 Diagnostics & Research names. WAT ranks #2 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
6,555 | $3,286,414 | |
| 2 | WAT |
Waters Corp /De/
This page
|
1,462 | $548,308 |
All Filings in WAT
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $548,308 | 1,462 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $440,446 | 1,479 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $379,830 | 1,000 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $299,810 | 1,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $418,848 | 1,200 | Shares | Sole | 2025-09-04 | |
| 2025-03-31 | $442,284 | 1,200 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $445,176 | 1,200 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $431,868 | 1,200 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $348,144 | 1,200 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $413,076 | 1,200 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $395,076 | 1,200 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $329,052 | 1,200 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $319,848 | 1,200 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $371,556 | 1,200 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $411,096 | 1,200 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $323,436 | 1,200 | Shares | Sole | 2022-10-17 | |
| No filing history on record for this holder in this stock. | ||||||